Verano (OTCMKTS:VRNOF – Get Rating) is one of 32 public companies in the “Agricultural production – crops” industry, but how does it contrast to its rivals? We will compare Verano to related businesses based on the strength of its risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations.
This table compares Verano and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Valuation & Earnings
This table compares Verano and its rivals gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Verano Competitors||$1.63 billion||$92.76 million||1.33|
Insider and Institutional Ownership
26.9% of shares of all “Agricultural production – crops” companies are held by institutional investors. 20.6% of shares of all “Agricultural production – crops” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
This is a breakdown of recent recommendations for Verano and its rivals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Verano presently has a consensus price target of $26.25, indicating a potential upside of 365.43%. As a group, “Agricultural production – crops” companies have a potential upside of 71.01%. Given Verano’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Verano is more favorable than its rivals.
Verano Company Profile
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. It engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. The company offers artisanal cannabis products under the Encore, Avexia, MUV, and Verano brands for medical and adult-use markets. As of May 10, 2022, it operated 96 retail dispensaries, and 13 cultivation and processing facilities. The company is headquartered in Chicago, Illinois.
Receive News & Ratings for Verano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verano and related companies with MarketBeat.com's FREE daily email newsletter.